君实生物

- 688180

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
君实生物(688180) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入150,254.9998,645.7666,970.2725,515.45145,349.27
营业收入150,254.9998,645.7666,970.2725,515.45145,349.27
二、营业总成本381,185.95247,937.18177,281.4989,761.97410,293.13
营业成本54,097.6433,684.5025,215.568,551.2550,430.80
营业税金及附加1,970.431,343.50877.60358.091,041.27
销售费用84,435.5955,440.8537,312.6918,262.1771,570.44
管理费用53,643.9635,940.0223,230.4111,313.8456,908.75
财务费用-6,708.62-5,534.36-4,214.65-1,489.36-8,095.47
研发费用193,746.95127,062.6694,859.8852,765.99238,437.34
资产减值损失----------
公允价值变动收益-14,917.74-4,584.82-2,776.62-612.48-927.66
投资收益7,399.04-4,486.65-2,807.06-1,385.92-4,193.24
其中:对联营企业和合营企业的投资收益-6,048.47-4,910.10-3,230.52-1,562.57-7,103.14
汇兑收益----------
三、营业利润-245,744.24-158,036.27-116,229.20-63,321.83-266,591.44
加:营业外收入391.33392.89361.180.4568.30
减:营业外支出3,816.553,108.161,814.41424.011,195.29
其中:非流动资产处置损失----------
四、利润总额-249,169.46-160,751.54-117,682.43-63,745.39-267,718.43
减:所得税费用4,399.47-5,238.65-5,049.48216.61-9,310.68
五、净利润-253,568.93-155,512.89-112,632.95-63,961.99-258,407.75
归属于母公司所有者的净利润-228,343.19-140,681.84-99,741.24-54,343.23-238,804.99
少数股东损益-25,225.74-14,831.05-12,891.71-9,618.76-19,602.76
六、每股收益
基本每股收益(元/股)-2.3200-1.4300-1.0100-0.5500-2.6000
稀释每股收益(元/股)-2.3200-1.4300-1.0100-0.5500-2.6000
七、其他综合收益-7,365.85-5,073.28-3,817.82-2,744.73-6,861.77
八、综合收益总额-260,934.78-160,586.17-116,450.77-66,706.72-265,269.51
归属于母公司所有者的综合收益总额-235,709.03-145,755.12-103,559.06-57,087.96-245,666.76
归属于少数股东的综合收益总额-25,225.74-14,831.05-12,891.71-9,618.76-19,602.76
下载全部历史数据到excel中 返回页顶